What is Starpharma Holdings about?
Starpharma (ASX:SPL) is an Australian biopharmaceutical company developing novel therapeutics and improving existing pharmaceuticals using its proprietary dendrimer technology. Starpharma's portfolio includes multiple clinical-stage oncology products which use its DEP (Dendrimer Enhanced Product) drug delivery technology, and marketed products including Viraleze and VivaGel. Starpharma has multiple DEP partnerships with international biopharmaceutical companies, including AstraZeneca, MSD, and Chase Sun.
Is Starpharma Holdings a public or private company?
How many people does Starpharma Holdings employ?
What sector is Starpharma Holdings in?
Where is the head office for Starpharma Holdings?
What year was Starpharma Holdings founded?
Where does Starpharma Holdings operate? Locations of Starpharma Holdings global operations
- Global view
- Melbourne, Australia
What are Starpharma Holdings’s services?
Overview of Starpharma Holdings offerings
SPL7013- also known as VivaGel or astodrimer sodium, is an innovative proprietary antiviral dendrimer that also blocks bacteria.
VIRALEZE Nasal Spray: A broad-spectrum nasal spray trapping and blocking cold/respiratory viruses. Registered as a medical device in various countries.
VivaGel BV: A non-antibiotic vaginal gel for bacterial vaginosis, registered as a medical device in 45+ countries and sold under different brand names globally.
VivaGel Condom: The world's first antiviral condom lubricated with VivaGel, providing primary protection against sexually transmitted infections.
Who is in the Starpharma Holdings executive team?
Starpharma Holdings leadership team
- Dr. Jacinth K. Fairley B.Sc., B.V.Sc.(Hons), GAICD, MBACEO, MD & Exec. Director
- Mr. Nigel J. Baade B.Com, Grad. Dip., CPACFO & Company Sec.